Buy Flagnea Caffeine Citrate USP

Flagnea (Caffeine Citrate USP) is a prescription medication available in 20mg/ml vials, commonly used for neonatal apnea management. This sterile citrate formulation supports respiratory function in premature infants. Ideal for hospital and clinical settings, it provides precise dosing in a convenient single-use vial.

Strength

20mg/ml-1ml

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Flagship Biotech International

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Caffeine citrate is primarily used to treat neonatal apnea, a condition where premature infants experience pauses in breathing. It works by stimulating the central nervous system to improve respiratory drive. Healthcare providers may also use it off-label for other conditions involving respiratory depression in newborns. This medication helps stabilize breathing patterns and reduce the frequency of apneic episodes.

Side Effects

Flagnea (Caffeine Citrate USP) helps regulate breathing by acting as a mild stimulant on the central nervous system. Patients may experience improved oxygenation and reduced instances of apnea. The effects typically become noticeable within hours of administration, with some infants showing better feeding tolerance. Monitoring is recommended to assess individual response.

Precautions & Warnings

Store Flagnea vials at room temperature, away from moisture and direct light. Always check the vial for particles or discoloration before use. Administer only under the supervision of a healthcare professional, as improper dosing may lead to adverse effects. Keep out of reach of children and pets. Discard any unused portion after opening.

Avoid Interactions

Caffeine citrate may interact with other central nervous system stimulants, increasing the risk of overstimulation. Concurrent use with CYP1A2 inhibitors, such as certain antibiotics or antidepressants, can elevate caffeine levels in the blood. Alcohol and nicotine may also alter its effects. Always inform your healthcare provider about all medications being taken.

References

Frequently Asked Questions

Flagnea (Caffeine Citrate USP) is used to treat neonatal apnea in premature infants by stimulating breathing.

It is administered as an intravenous injection or oral solution, as directed by a healthcare professional.

No, Flagnea should only be used under medical supervision in a clinical setting.

Possible side effects include increased heart rate, restlessness, or gastrointestinal upset.

Flagnea is prescribed for premature infants with apnea but requires careful monitoring by a doctor.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.